Popular Topics

iNNCOVACC is the world’s first intranasal COVID19 vaccine to receive approval for the primary 2-dose schedule, and as a heterologous booster dose. It is developed by Bharat Biotech International Limited (BBIL) in collaboration with Biotechnology Industry Research Assistance (BIRAC), a PSU under the Dept of Biotechnology, Ministry of Science and Technology.

Government has launched the 75 days - ‘COVID Vaccination Amrit Mahotsava’ from 15th July 2022 to provide free Precaution Dose at all adult (18 years and above) eligible population at Government COVID Vaccination Centres (CVCs).

It has been decided that precaution dose of COVID vaccines will be made available to 18+ population group at private vaccination centres. The administration of Precaution Dose to 18+ population through Private Vaccination Centres would start from 10th April (Sunday), 2022.

Ministry of Health and Family Welfare has launched the nationwide expansion of Pneumococcal Conjugate Vaccine (PCV) under the Universal Immunization Programme (UIP) .

This topic provides information about Guidelines for COVID-19 vaccination of children between 12-1A years of age.

This topic provides information about Frequently Asked Questions on COVID vaccines

Provides information about the common ailments that can be expected after COVID vaccination

This topic provides information about Precautions and Contraindications for COVID-19 Vaccination.

Provides information about the actionable toolkit designed by Ministry of Health & Family Welfare (MoHFW) to encourage eligible citizens who are above 18 years of age - to become Youth Champions in the fight against COVID-19 supporting the #LargestVaccineDrive and COVID Appropriate Behaviour (CAB).

The topic gives the detailed vaccination schedule to be carried out for goats.